PFE vs MRK: which stock is the better buy?
Pfizer Inc. and Merck & Co., Inc., graded by the same fixed-weight model from live fundamentals — composite score, 12-month forecast, valuation, growth and margins, side by side. As of July 6, 2026.
On today’s numbers, Merck & Co., Inc. grades higher — 62/100 vs 60/100. Tap either card for the full factor breakdown.
Metric by metric
| Metric | PFE | MRK |
|---|---|---|
| TradersQuant Score | 60/100 | 62/100 ✓ |
| Price | $24.32 | $129.52 |
| 12-mo base forecast | $25.70 | $187.50 |
| Implied upside | +5.7% | +44.8% ✓ |
| Bull / bear range | $28.72 / $24.23 | $204.47 / $180.20 |
| P/E | 18.6 ✓ | 36.4 |
| Forward P/E | — | — |
| Revenue growth (YoY) | -1.6% | +1.2% ✓ |
| Gross margin | 69.3% | 75.9% ✓ |
| Market cap | $138.6B | $319.9B |
| Sector | Healthcare | Healthcare |
✓ marks the stronger reading per metric (lower is better for P/E). Figures refresh continuously; research, not financial advice.
Want the full verdict on PFE and MRK?
The AI bull/base/bear thesis, smart-money positioning, options signals and insider activity on both — every systematic call graded in public against the S&P 500.
$0 today · cancel before day 7 and you won’t be charged
PFE vs MRK — FAQ (2026)
Is PFE or MRK the better buy right now?
On the live TradersQuant composite score, Merck & Co., Inc. (MRK) currently grades higher at 62/100 versus 60/100 for PFE. The score weighs valuation, growth, earnings quality, momentum, the macro regime, sentiment and balance-sheet risk — open each stock's page for the full breakdown. Research, not financial advice.
Which has more 12-month upside, PFE or MRK?
TradersQuant's 12-month base-case forecast currently implies +5.7% for PFE and +44.8% for MRK. Both forecasts are three-scenario models (bull/base/bear) refreshed continuously and graded on our public track record.
How is this PFE vs MRK comparison calculated?
Both stocks are scored by the same fixed-weight model — 20% valuation, 20% growth, 15% earnings quality, 15% momentum, 10% macro regime fit, 10% analyst sentiment, 10% balance-sheet risk — from live fundamentals and prices. No hand-picking: the same arithmetic runs on every stock we cover, and our systematic calls are graded in public against the S&P 500.